FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia.
Sung PJ, Selvam M, Riedel SS, Xie HM, Bryant K, Manning B, Wertheim GB, Kulej K, Pham L, Bowman RL, Peresie J, Nemeth MJ, Levine RL, Garcia BA, Meyer SE, Sidoli S, Bernt KM, Carroll M.
Sung PJ, et al.
Leukemia. 2024 Feb;38(2):291-301. doi: 10.1038/s41375-023-02131-4. Epub 2024 Jan 5.
Leukemia. 2024.
PMID: 38182819